Concepedia

Publication | Closed Access

Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study

386

Citations

11

References

2010

Year

References

YearCitations

Page 1